Here are the 424B prospectus supplements from Xcel Brands Inc. (XELB) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow XELB and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full XELB filings page.
Xcel Brands, Inc. (XELB) is offering up to $2,971,157 of common stock under a prospectus supplement as part of its shelf registration, using an at-the-market sales program with Maxim Group LLC as sales agent. The underlying sales agreement permits offerings of up to $10,000,000 of common stock, but this supplement is constrained by Form S-3 General Instruction I.B.6.
Shares will be sold from time to time on Nasdaq as "at the market offerings" at prevailing prices, with Maxim receiving a 3% commission on gross proceeds. XELB’s stock trades on the Nasdaq Capital Market under the symbol XELB; the last reported price on August 14, 2026 was $0.94 per share. Based on 6,560,274 shares outstanding as of that date, an illustrative sale of 3,160,805 shares at $0.94 would increase shares outstanding to 9,721,079.
Xcel expects to use net proceeds for working capital and general corporate purposes. As of June 30, 2026, the company reported total assets of approximately $32.5 million, cash of $399,000, and a working capital deficit of about $4.0 million. Net tangible book value was approximately $(2.35) per share; on the illustrative ATM sale, adjusted net tangible book value would improve to about $(1.29) per share, implying immediate dilution of roughly $2.23 per share to new investors.